Genomic newborn screening as a paradigm shift in rare disease management, with emphasis on endocrine conditions
{{output}}
Introduction: Genome sequencing (GS) is reshaping newborn screening (NBS) by enabling the early detection of a broader range of rare, treatable and/or actionable disorders. In the context of rapid therapeutic advances, internatio... ...
